These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28988790)

  • 21. The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy.
    Wong MC; Ching JY; Chan VC; Sung JJ
    Sci Rep; 2015 Sep; 5():13568. PubMed ID: 26338314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
    Hassan C; Zullo A; Winn S; Morini S
    Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score.
    Sekiguchi M; Igarashi A; Sakamoto T; Saito Y; Esaki M; Matsuda T
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1555-1561. PubMed ID: 32167186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Introduction.
    Lansdorp-Vogelaar I; von Karsa L;
    Endoscopy; 2012 Sep; 44 Suppl 3():SE15-30. PubMed ID: 23012118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT colonography to screen for colorectal cancer and aortic aneurysm in the Medicare population: cost-effectiveness analysis.
    Pickhardt PJ; Hassan C; Laghi A; Kim DH
    AJR Am J Roentgenol; 2009 May; 192(5):1332-40. PubMed ID: 19380558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis.
    Greuter MJ; Berkhof J; Fijneman RJ; Demirel E; Lew JB; Meijer GA; Stoker J; Coupé VM
    Br J Radiol; 2016 Jul; 89(1063):20150910. PubMed ID: 27194458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Faecal occult blood testing for colorectal cancer screening: the past or the future.
    Benton SC; Seaman HE; Halloran SP
    Curr Gastroenterol Rep; 2015 Feb; 17(2):428. PubMed ID: 25673567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of CT colonography for colorectal cancer screening on the UK NHS: costs, healthcare resources and health outcomes.
    Sweet A; Lee D; Gairy K; Phiri D; Reason T; Lock K
    Appl Health Econ Health Policy; 2011; 9(1):51-64. PubMed ID: 21174482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colon capsule versus computed tomography colonography for colorectal cancer screening in patients with positive fecal occult blood test who refuse colonoscopy: a randomized trial.
    Pioche M; Ganne C; Gincul R; De Leusse A; Marsot J; Balique J; Fond A; Bretagnolle M; Henry L; Billaud Y; Malezieux R; Lapalus MG; Chambon-Augoyard C; Del Tedesco E; Scalone O; Montoy JC; Russias B; Detry A; Veniat F; Qiu J; Valette PJ; Taillandier A; Saurin JC; Tomczyk-Ferrero J; Gandilhon C; Vecchiato L; Soler-Michel P; Ponchon T
    Endoscopy; 2018 Aug; 50(8):761-769. PubMed ID: 29486502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternatives to colonoscopy for population-wide colorectal cancer screening.
    Leung WC; Foo DC; Chan TT; Chiang MF; Lam AH; Chan HH; Cheung CC
    Hong Kong Med J; 2016 Feb; 22(1):70-7. PubMed ID: 26744124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controversies in colorectal cancer screening.
    Pox CP
    Digestion; 2014; 89(4):274-81. PubMed ID: 25034478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.
    Ladabaum U; Allen J; Wandell M; Ramsey S
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1567-76. PubMed ID: 23796793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on Flexible Sigmoidoscopy, Computed Tomographic Colonography, and Capsule Colonoscopy.
    Chung SW; Hakim S; Siddiqui S; Cash BD
    Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):569-583. PubMed ID: 32439089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy.
    Hassan C; Zullo A; Laghi A; Reitano I; Taggi F; Cerro P; Iafrate F; Giustini M; Winn S; Morini S
    Dig Liver Dis; 2007 Mar; 39(3):242-50. PubMed ID: 17112797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel molecular screening approaches in colorectal cancer.
    Miller S; Steele S
    J Surg Oncol; 2012 Apr; 105(5):459-67. PubMed ID: 22441897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer screening: An updated review of the available options.
    Issa IA; Noureddine M
    World J Gastroenterol; 2017 Jul; 23(28):5086-5096. PubMed ID: 28811705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost analysis of colorectal cancer screening with CT colonography in Italy.
    Mantellini P; Lippi G; Sali L; Grazzini G; Delsanto S; Mallardi B; Falchini M; Castiglione G; Carozzi FM; Mascalchi M; Milani S; Ventura L; Zappa M
    Eur J Health Econ; 2018 Jun; 19(5):735-746. PubMed ID: 28681075
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.